Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Tumor-infiltrating lymphocytes and the PD-L1/PD-1 signaling axis in breast cancer: biology and clinical implications | Semantic Scholar
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis Zerdes - Greece | Professional Profile | LinkedIn
PDF) Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Οδοντιατρείο Ιωάννης Ζερδές - Home | Facebook
TOKYO, JAPAN - AUGUST 8: Silver for team Greece with head coach Theodoros Vlachos of Greece, Emmanouil Zerdevas of Greece, Konstantinos Genidounias of Greece, Dimitrios Skoumpakis of Greece, Marios Kapotsis of Greece,
111 Ioannis Fountoulis Photos and Premium High Res Pictures - Getty Images
Οδοντιατρείο Ιωάννης Ζερδές - Home | Facebook
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Zerdes Ioannis Katsiapis Nikolaos in Pireas, Greece Information and Review
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of
